文献速递肿瘤 PET/CT核素与放射性配体治疗

68Ga标记前列腺特异性膜抗原PET/CT检测前列腺癌患者同步原发恶性肿瘤:764例患者中的发生率

Detection of Synchronous Primary Malignancies with 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients.
PubMed 文献 · J Nucl Med · 2017-06-01

回顾性分析764例前列腺癌患者68Ga标记前列腺特异性膜抗原PET/CT报告,49例(6.4%)发现非典型前列腺癌转移的病灶,最终5例(0.7%)确诊同步原发恶性肿瘤(2例肺癌、1例淋巴瘤、1例甲状腺癌、1例舌根癌),8例(1.0%)证实为前列腺癌非典型转移,24例(3.1%)为良性病因,12例(1.6%)无随访资料。

要点

  • 764例前列腺癌患者中,49例(6.4%)68Ga-PSMA PET/CT发现非典型病灶。
  • 同步原发恶性肿瘤确诊5例(0.7%),包括肺癌2例、淋巴瘤1例、甲状腺癌1例、舌根癌1例。
  • 非典型病灶更常见为前列腺癌非典型转移(1.0%)或良性病因(3.1%)。

核心结论

  • 前列腺癌患者中68Ga标记前列腺特异性膜抗原亲和性同步原发恶性肿瘤罕见(0.7%),非典型病灶更常见为不寻常的前列腺癌转移(1.0%)或良性病因(3.1%)。

研究设计与样本

  • 回顾性审查764例前列腺癌患者的68Ga标记前列腺特异性膜抗原PET/CT报告,识别提示同步原发恶性肿瘤的非典型前列腺癌转移病灶,并获取随访确认病因。

主要发现

  • 49例(6.4%)患者中发现非典型前列腺癌转移的病灶。
  • 5例(0.7%)确诊同步原发恶性肿瘤:2例肺癌、1例淋巴瘤、1例甲状腺癌、1例舌根癌。
  • 8例(1.0%)病灶证实为前列腺癌非典型转移。
  • 24例(3.1%)病灶为良性病因。
  • 12例(1.6%)无随访资料。

局限性

  • 12例(1.6%)患者无随访资料。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We evaluated the incidence of synchronous primary malignancies in patients undergoing 68Ga-labeled prostate-specific membrane antigen PET/CT for prostate cancer (PC). Methods: Reports for 764 PC patients were reviewed. Incidental lesions atypical for PC metastases and suggestive of a synchronous primary malignancy were identified. Follow-up was obtained to confirm etiology. Results: Lesions atypical for PC metastases were found in 49 (6.4%) of 764 patients, and a synchronous primary malignancy was confirmed in 5 patients (0.7%; 2 lung, 1 lymphoma, 1 thyroid, and 1 base of tongue). In 8 patients (1.0%), lesions were proven to be atypical metastases from PC. In 24 patients (3.1%), lesions had a benign etiology. Follow-up was not available in 12 patients (1.6%). Conclusion: Synchronous 68Ga-labeled prostate-specific membrane antigen-avid malignancies were rare (0.7%) in PC patients; atypical lesions were more commonly unusual PC metastases (1.0%) or benign (3.1%).

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Osman MM, Iravani A, Hicks RJ, et al. Detection of Synchronous Primary Malignancies with 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients. J Nucl Med. 2017. PMID: 28572488. doi:10.2967/jnumed.117.190215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。